October 21, 2013 | The Economic Times of India reports that the Indian Supreme Court has ruled that all clinical trials in the country must be for the benefit of the Indian population and not "multinational companies." 157 trials already approved have been halted; five trials were approved to carry on. For the 157 trials--and any in the future--consent of all participants must be obtained and recorded audio visually, and the trials must be cleared by two committees. According to affidavit's submitted during the hearings, 2,644 people died in India during clinical trials of 475 new drugs between 2005 to 2012. For background on clinical trials in India, see our report from earlier this year.